Your browser doesn't support javascript.
loading
DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFß/PD-L1 Targeted Cancer Immunotherapy.
Carr, Michael I; Chiu, Li-Ya; Guo, Yige; Xu, Chunxiao; Lazorchak, Adam S; Yu, Huakui; Qin, Guozhong; Qi, Jin; Marelli, Bo; Lan, Yan; Sun, Qing; Czauderna, Frank; Zenke, Frank T; Blaukat, Andree; Vassilev, Lyubomir T.
Afiliação
  • Carr MI; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Chiu LY; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Guo Y; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Xu C; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Lazorchak AS; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Yu H; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Qin G; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Qi J; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Marelli B; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Lan Y; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Sun Q; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Czauderna F; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
  • Zenke FT; Translational Innovation Platform Oncology and Immuno-Oncology, Merck KGaA, Darmstadt, Germany.
  • Blaukat A; Translational Innovation Platform Oncology and Immuno-Oncology, Merck KGaA, Darmstadt, Germany.
  • Vassilev LT; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts.
Mol Cancer Res ; 20(4): 568-582, 2022 04 01.
Article em En | MEDLINE | ID: mdl-34980594
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article